Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis

NCT00629941 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharitis

Interventions

DRUG: AzaSite®

Sponsor

Merck Sharp & Dohme LLC